BioSpace News Archive

The rapid expansion of global immunotherapy drugs market is a result of growing demand for immunotherapy drugs instead of traditional treatment therapies, and increased pervasiveness of autoimmune ailments, cancers, and other infectious diseases.

UMF Corporation today announced that testing from award-winning contract research organization Integrated Pharma Services confirms that UMF’s Micrillon® sheath and core fiber demonstrates significant antiviral properties against Human Coronavirus, which causes COVID-19, and Human Influenza A H1N1 virus in just minutes

OmniTier today announced that its genomic secondary analysis appliance, CompStor Novos®, has added somatic variant calling from matched, whole genome sequencing (WGS) tumor-normal sample pairs.

The escalating prevalence of chronic acne globally will augment the acne medication industry growth in the forthcoming years.

Expansion of the geriatric population base and the consistent prevalence of cancer will drive the demand for biopsy devices.

An increasing number of patients suffering from life-threatening genetic disorders will play a crucial role in augmenting cord blood banking market share in the future.

The growing number of people who have diabetes due to sedentary and erratic lifestyles along with unhealthy diet habits will augment demand for diabetes care devices, which help in monitoring levels of glucose in the blood.

Electronic health record (EHR) market has witnessed some exciting trends over the past few years and will continue to experience robust transformation in the future.

The APAC cell line development market forecast is slated to witness an upsurge owing to the escalating demand for monoclonal vaccine and monoclonal antibodies, especially in the light of the present-day COVID -19 pandemic.

Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”), a leader in the growing field of cancer metabolism-based therapeutics, today announced that Sanjeev Luther, President and CEO, and Timothy S. Pardee, M.D., Ph.D., Co-Chief Medical Officer of the Company, will present at the B. Riley Securities Virtual Oncology Investor Conference on Wednesday, Jan. 20. “As we kick off 2021, we are excited to present the progress that Rafael Pharma